CIK 0000873303
- Large accelerated filer
Sarepta Therapeutics, Inc.
Sign in to watch- Ticker
- SRPT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 930797222
- Phone
- +1 617-274-4000
- Business address
- 215 FIRST STREET, SUITE 415, CAMBRIDGE, MA, 02142
- Former names
- Sarepta Therapeutics, Inc., AVI BIOPHARMA INC, ANTIVIRALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-03-15 | Cumbo Alexander SVP, Chief Commercial Officer | Exercise or conversion · Stock option (right to buy) | −1,370 | 11,415 | ||
| 2018-03-15 | Mahatme Sandesh EVP, CFO & CBO | Exercise or conversion | +2,500 | $23.85 | $60K | 43,395 |
| 2018-03-15 | Mahatme Sandesh EVP, CFO & CBO | Shares withheld for taxes | −734 | $81.22 | $60K | 42,661 |
| 2018-03-15 | Mahatme Sandesh EVP, CFO & CBO | Exercise or conversion · Stock option (right to buy) | −2,500 | 11,768 | ||
| 2018-03-05 | Wigzell Hans Lennart Rudolf Director | Grant or award | +3,418 | 10,084 | ||
| 2018-03-05 | Wigzell Hans Lennart Rudolf Director | Grant or award · Stock option (right to buy) | +4,820 | 4,820 | ||
| 2018-03-05 | Ruff Shamim SVP, Chief Regulatory Affairs | Grant or award · Stock option (right to buy) | +70,000 | 70,000 | ||
| 2018-03-05 | Nicaise Claude Director | Grant or award | +3,418 | 5,418 | ||
| 2018-03-05 | Nicaise Claude Director | Grant or award · Stock option (right to buy) | +4,820 | 4,820 | ||
| 2018-03-05 | Mahatme Sandesh EVP, CFO & CBO | Grant or award · Stock option (right to buy) | +97,500 | 97,500 | ||
| 2018-03-05 | Howton David T SVP, General Counsel | Grant or award · Stock option (right to buy) | +70,000 | 70,000 | ||
| 2018-03-05 | Cumbo Alexander SVP, Chief Commercial Officer | Grant or award · Stock option (right to buy) | +70,000 | 70,000 | ||
| 2018-03-05 | BONNEY MICHAEL W Director | Grant or award | +3,418 | 3,418 | ||
| 2018-03-05 | BONNEY MICHAEL W Director | Grant or award · Stock option (right to buy) | +4,820 | 4,820 | ||
| 2018-03-05 | BEHRENS M KATHLEEN Director | Grant or award | +3,418 | 116,534 | ||
| 2018-03-05 | BEHRENS M KATHLEEN Director | Grant or award · Stock option (right to buy) | +4,820 | 4,820 | ||
| 2018-03-05 | Basi Guriqbal S. SVP, Chief Scientific Officer | Grant or award · Stock option (right to buy) | +70,000 | 70,000 | ||
| 2018-03-05 | Barry Richard Director | Grant or award | +3,418 | 3,245,432 | ||
| 2018-03-05 | Barry Richard Director | Grant or award · Stock option (right to buy) | +4,820 | 4,820 | ||
| 2017-12-04 | BONNEY MICHAEL W Director | Grant or award · Non-Qualified Stock Options (right to buy) | +16,400 | 16,400 |
Page 37 of 38 · 760 trades